J. M. Lange

Antiretroviral therapy in previously untreated adults infected with the human immunodeficiency virus type I: established and potential determinants of virological outcome.

J. Prins, J. Lange, S. Lowe, 2004, The Netherlands journal of medicine.

Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996–2001

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2003, AIDS.

[CBO guidelines 'Antiretroviral therapy in the Netherlands'].

S. Danner, J. Borleffs, J. V. van Everdingen, 2001, Nederlands tijdschrift voor geneeskunde.

Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2004, AIDS.

Indinavir/ritonavir 800/100 mg bid and efavirenz 600 mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors: 96‐week outcomes of HIV‐NAT 009

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2005, HIV medicine.